Lecture 26 - Malignant Lung Pathology Flashcards

1
Q

What is a lung tumour?

A

tumours within the lung that possess lethal abnormal characteristic that enables them to invade and metastasize/ spread to other tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What proportion of primary malignant lung tumours are carcinomas

A

more than 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 4 types of carcinomas

A

squamous cell carcinoma - 20-30%
small cell carcinoma - 15-205
adenocarcinoma - 30-40%
large cell undifferentiated carcinoma - 10-15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are carcinoid tumours?

A

low grade malignant tumours, better survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are malignant mesenchymal tumours?

A

very rare, most common type is synovial sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are primary lung lymphomas?

A

Rare, can be seen in HIV/AIDS patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are secondary lung tumours?

A

Very common, more common than primary tumours

Usually present as multiple discrete nodules, can also be solitary

Most common are carcinomas from various sites eg. Breast, GI tract, Kidney
Sarcomas
Melanomas
Lymphomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Epidemiology of lung cancer

A

Most common cause of cancer death in the UK.
In the UK around 45,000 new cases are diagnosed each year and > 30,000 deaths/year

Males slightly more than females

Major public health problem

Age usually between 40-70,
rare in younger individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a major risk factor for lung cancer

A

cigarette smoking

incidence and mortality rates have been decreasing in men since 1990’s, due to decrease smoking rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the overall prognosis for lung cancer?

A

Poor

5 year survival is between 5-10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the aetiology of lung cancer?

A

tobacco smoking
occupational/industrial hazards - asbestos, uranium, arsenic, nickel

Radiation - mines in which there is radon
-survivors of the atomic bomb in Japan after 2nd world war had a high incidence of lung cancer

Lung fibrosis - old terminology ‘scar cancers’ has been challenged
- increase risk of lung cancer in patients with pulmonary fibrosis

  • Genetic mutations EGFR, KRAS, ALK etc
  • usually seen lung cancers in never smokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the pathogenesis of lung cancer?

A

Not very well understood.

Mutations in key genes regulating cell profileration, DNA repair and apoptosis

Squamous carcinoma - cigarette smoking is an irritant,

(squamous metaplasia - dysplasia - carcinoma in-situ - frank squamous carcinoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the effect of cigarette/tobacco smoking on lung cancer

A

it is a major risk factor
tobacco smoke is a carcinogen
almost linear relationship between no. of cigarettes smoked daily and risk of developing lung cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a ‘pack year’?

A

1 pack year - 20 cigarettes per day for 1 year

-40 cigarettes per day for 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Does passive smoking increase risk for lung cancer

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Where do 2/3rd of world smokers reside?

A

china

lung cancer death in china is expected to run into millions by mid-21st century

17
Q

What is the latent period between asbestos exposure and development of carcinoma

A

about 20 years

18
Q

How much is risk of lung cancer increased of asbestos in combination with cigarette smoking

A

20-100 fold

19
Q

What other respiratory illnesses is asbestos exposure associated with?

A

lung fibrosis and mesothelioma (malignant tumour of the pleura)

20
Q

what are the clinical features of lung cancer?

A

local effects of tumour
distant metastases
non-specific features
asymptomatic, discovered incidentally

21
Q

What are local effects of lung cancer?

A

Central tumours arising in proximal airways can ulcerate and bleed - haemoptysis

Tumour obstructing airways with distal collapse or consolidation - breathlessness or features of pneumonia

tumour infiltrating into adjacent structures eg.

pleura - pleura effusion presenting as breathlessness

22
Q

Tumour infiltrating into pleura

A

pleural effusion presenting as breathlessness

23
Q

Tumour infiltrating into chest wall/ribs

A

pain

24
Q

Tumour infiltrating into recurrent laryngeal nerve

A

hoarseness

25
Q

Tumour infiltrating into oesophagus

A

dysphagia

26
Q

Tumour infiltrating into sympathetic trunk

A

horner’s syndrome -sympathetic chain - combination of symptoms

27
Q

How can distant metastases present?

A

with disseminated disease

common sites - lymph nodes, pleura, liver, bone, adrenal, brain

Depending on the site can present with pathological fractures, seizures, lumps in neck etc.

28
Q

What are the non-specific features of lung cancer?

A
  • Usually metabolic effects
  • Weight loss, lethargy
  • Electolytic disturbances, eg small cell carcinoma - hyponatraemia, hypokalaemia, hypercalcaemia in SCC
  • Finger clubbing
29
Q

What is lymphangitis carcinomatosa?

A

Lymphatics within the lung are diffusely involved by tumour

30
Q

What is the management of lung cancer?

A

a small % of patients diagnosed with early stage (limited to lung or extension into local nodes), are offered surgery or radical radiotherapy

Majority present with advanced disease - until recently options were limited to chemotherapy or palliative radiotherapy

31
Q

Recent advances in treatment of lung cancer with advanced disease

A
  • Target/tailored therapy
  • based on tumour genomics eg. EGFR mutations, ALK re-arrangements
  • Immune checkpoint inhibitors eg. PD- L1